Addus HomeCare Co. (NASDAQ:ADUS) Shares Bought by Louisiana State Employees Retirement System

Louisiana State Employees Retirement System lifted its holdings in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 7.4% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 8,700 shares of the company’s stock after buying an additional 600 shares during the period. Louisiana State Employees Retirement System’s holdings in Addus HomeCare were worth $1,157,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. UMB Bank n.a. raised its position in Addus HomeCare by 64.2% during the second quarter. UMB Bank n.a. now owns 225 shares of the company’s stock worth $26,000 after acquiring an additional 88 shares during the period. Quest Partners LLC acquired a new position in shares of Addus HomeCare during the 2nd quarter worth about $31,000. Innealta Capital LLC purchased a new position in Addus HomeCare in the 2nd quarter valued at about $44,000. EntryPoint Capital LLC acquired a new stake in Addus HomeCare in the 1st quarter worth about $44,000. Finally, Sandia Investment Management LP purchased a new stake in Addus HomeCare during the 2nd quarter worth approximately $58,000. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Insider Activity

In related news, EVP Michael D. Wattenbarger sold 21,917 shares of the business’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $133.29, for a total value of $2,921,316.93. Following the sale, the executive vice president now directly owns 7,215 shares in the company, valued at approximately $961,687.35. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other news, Director Esteban Lopez sold 500 shares of the firm’s stock in a transaction on Wednesday, September 4th. The stock was sold at an average price of $130.03, for a total transaction of $65,015.00. Following the completion of the transaction, the director now directly owns 3,866 shares in the company, valued at $502,695.98. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Michael D. Wattenbarger sold 21,917 shares of Addus HomeCare stock in a transaction on Monday, August 26th. The shares were sold at an average price of $133.29, for a total value of $2,921,316.93. Following the completion of the sale, the executive vice president now directly owns 7,215 shares of the company’s stock, valued at $961,687.35. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 22,917 shares of company stock valued at $3,050,082 in the last quarter. Insiders own 4.60% of the company’s stock.

Wall Street Analyst Weigh In

ADUS has been the topic of several research reports. Stephens restated an “overweight” rating and issued a $138.00 target price on shares of Addus HomeCare in a research report on Tuesday, August 6th. TD Cowen lifted their target price on shares of Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a research note on Thursday, August 8th. KeyCorp started coverage on shares of Addus HomeCare in a research report on Friday, October 11th. They issued an “overweight” rating and a $150.00 target price for the company. StockNews.com lowered shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research report on Sunday, July 7th. Finally, Royal Bank of Canada reiterated an “outperform” rating and issued a $141.00 price objective on shares of Addus HomeCare in a report on Tuesday, September 3rd. One investment analyst has rated the stock with a sell rating, eight have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $131.38.

Addus HomeCare Price Performance

NASDAQ:ADUS opened at $126.27 on Friday. The company’s 50-day moving average is $130.02 and its two-hundred day moving average is $120.10. Addus HomeCare Co. has a 1-year low of $80.68 and a 1-year high of $136.12. The firm has a market capitalization of $2.29 billion, a price-to-earnings ratio of 29.92, a PEG ratio of 2.28 and a beta of 1.04.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings data on Monday, August 5th. The company reported $1.35 EPS for the quarter, beating analysts’ consensus estimates of $1.21 by $0.14. The firm had revenue of $286.90 million for the quarter, compared to analysts’ expectations of $284.90 million. Addus HomeCare had a return on equity of 9.81% and a net margin of 6.18%. The firm’s quarterly revenue was up 10.4% on a year-over-year basis. During the same period in the prior year, the firm posted $0.94 earnings per share. As a group, equities analysts anticipate that Addus HomeCare Co. will post 4.57 earnings per share for the current fiscal year.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.